Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase

被引：6
|
作者：
Wilcoxen, Keith M. [1 ]
Brake, Rachael L. [2 ]
Saffran, Doug [2 ]
Teffera, Yohannes [2 ]
Choguette, Deborah [2 ]
Whittington, Doug [2 ]
Yu, Violeta [2 ]
Romero, Karina [2 ]
Bode, Christiane [2 ]
Stellwagen, John [2 ]
Potashman, Michelle [2 ]
Emkey, Renee [2 ]
Andrews, Paul [2 ]
Drew, Allison E. [2 ]
Xu, Man [2 ]
Szilvassy, Stephen [3 ]
Al-Assad, Samer [3 ]
Lewis, Richard T. [2 ]
机构：
[1] Tesaro Inc, Waltham, MA USA
[2] Amgen Inc, Cambridge, MA USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1795
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1795
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Ligand-based pharmacophore modelling in search of novel anaplastic lymphoma kinase inhibitors
    Gajulapalli, V. Pratap Reddy
    Lee, Juyong
    Sohn, Insuk
    RESULTS IN CHEMISTRY, 2023, 5
  • [42] Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase
    Mah, Shinmee
    Jang, Jaebong
    Song, Daesun
    Shin, Yongje
    Latif, Muhammad
    Jung, Yongwon
    Hong, Sungwoo
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2019, 17 (01) : 186 - 194
  • [43] Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors
    Tully, David C.
    Liu, Hong
    Chatterjee, Arnab K.
    Alper, Phil B.
    Williams, Jennifer A.
    Roberts, Michael J.
    Mutnick, Daniel
    Woodmansee, David H.
    Hollenbeck, Thomas
    Gordon, Perry
    Chang, Jonathan
    Tuntland, Tove
    Tumanut, Christine
    Li, Jun
    Harris, Jennifer L.
    Karanewsky, Donald S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (19) : 5107 - 5111
  • [44] Impact of Hydrolysis-Mediated Clearance on the Pharmacokinetics of Novel Anaplastic Lymphoma Kinase Inhibitors
    Teffera, Yohannes
    Berry, Loren M.
    Brake, Rachael L.
    Lewis, Richard T.
    Saffran, Douglas C.
    Moore, Earl
    Liu, Jingzhou
    Zhao, Zhiyang
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 238 - 247
  • [45] Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
    Liau, Nicholas P. D.
    Laktyushin, Artem
    Morris, Rhiannon
    Sandow, Jarrod J.
    Nicola, Nicos A.
    Kershaw, Nadia J.
    Babon, Jeffrey J.
    CANCERS, 2019, 11 (11)
  • [46] Discovery of Potent and Selective Inhibitors of Wild-Type and Gatekeeper Mutant Fibroblast Growth Factor Receptor (FGFR) 2/3
    Shvartsbart, Artem
    Roach, Jeremy J.
    Witten, Michael R.
    Koblish, Holly
    Harris, Jennifer J.
    Covington, Maryanne
    Hess, Rodrigo
    Lin, Luping
    Frascella, Michelle
    Truong, Lisa
    Leffet, Lynn
    Conlen, Patricia
    Beshad, Elham
    Klabe, Ron
    Katiyar, Kamna
    Kaldon, Laura
    Young-Sciame, Ruth
    He, Xin
    Petusky, Susan
    Chen, Kwang-Jong
    Horsey, April
    Lei, Hsiang-Ting
    Epling, Leslie B.
    Deller, Marc C.
    Vechorkin, Oleg
    Yao, Wenqing
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (22) : 15433 - 15442
  • [47] ANAPLASTIC LYMPHOMA KINASE GENE REARRANGEMENT IN MALAYSIAN PATIENTS WITH EGFR WILD TYPE LUNG ADENOCARCINOMA
    Mohamad, N.
    Tan, J. L.
    Pailoor, J.
    Rajadurai, P.
    Liam, C. K.
    RESPIROLOGY, 2016, 21 : 43 - 43
  • [48] The development of potent, selective RET inhibitors that target both wild-type RET and prospectively identified resistance mutations to multi kinase inhibitors
    Rahal, Rami
    Evans, Erica K.
    Hu, Wei
    Maynard, Michelle
    Fleming, Paul
    DiPietro, Lucian
    Kim, Joseph L.
    Sheets, Michael P.
    Wilson, Doug P.
    Wilson, Kevin J.
    Stransky, Nicolas
    Brubaker, Jason D.
    Guzi, Timothy
    Kohl, Nancy E.
    Lengauer, Christoph
    CANCER RESEARCH, 2016, 76
  • [49] Lead optimization of a series of 5-aminopyrazol-imidazopyridine compounds as potent anaplastic lymphoma kinase inhibitors active against clinically relevant ALK mutations
    Yang, Bin
    Saeh, Jamal C.
    Peng, Bo
    Kamhi, Victor
    Harrison, Rane
    Harish, Reema
    Wu, Allan
    Whitston, David
    Wang, Haiyun
    Ye, Minwei
    Wang, Suping
    Code, Erin
    Rivard, Caroline
    Drew, Lisa
    Mazzola, Anne Marie
    Russell, Daniel J.
    CANCER RESEARCH, 2012, 72
  • [50] Cell Culture Modeling of Genotype-Directed Sensitivity to Selective Kinase Inhibitors: Targeting the Anaplastic Lymphoma Kinase (ALK)
    Settleman, Jeff
    SEMINARS IN ONCOLOGY, 2009, 36 (02) : S36 - S41
12345